{"data":[{"accessionNo":"0001104659-26-114761","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-09-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":342481,"percentOfClass":8.7,"filedAt":"2026-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-114761","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-09-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":342481,"percentOfClass":8.7,"filedAt":"2026-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-114761","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-09-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":342481,"percentOfClass":8.7,"filedAt":"2026-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-114761","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-09-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":312138,"percentOfClass":7.9,"filedAt":"2026-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-088300","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":269874,"percentOfClass":6.9,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-088300","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":269874,"percentOfClass":6.9,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-088300","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":269874,"percentOfClass":6.9,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-088300","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":249027,"percentOfClass":6.3,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-044451","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-04-13","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":225073,"percentOfClass":5.7,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-044451","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-04-13","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":225073,"percentOfClass":5.7,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-044451","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-04-13","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":225073,"percentOfClass":5.7,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-044451","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-04-13","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":198748,"percentOfClass":5,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-036184","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-03-24","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":198237,"percentOfClass":5,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-036184","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-03-24","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":198237,"percentOfClass":5,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001104659-26-036184","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":"918385204","securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2026-03-24","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":198237,"percentOfClass":5,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001699737-25-000029","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641489","issuerName":"VTV THERAPEUTICS INC.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2025-12-08","reportingPerson":"Srinivas Akkaraju","reportingCik":"0001253170","personType":"IN","sharesOwned":403942,"percentOfClass":9.9,"filedAt":"2025-12-09","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001699737-25-000029","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641489","issuerName":"VTV THERAPEUTICS INC.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2025-12-08","reportingPerson":"Samsara BioCapital GP, LLC","reportingCik":"0001888829","personType":"OO","sharesOwned":246484,"percentOfClass":6.2,"filedAt":"2025-12-09","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001699737-25-000029","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641489","issuerName":"VTV THERAPEUTICS INC.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2025-12-08","reportingPerson":"Samsara BioCapital, L.P.","reportingCik":"0001699737","personType":"PN","sharesOwned":246484,"percentOfClass":6.2,"filedAt":"2025-12-09","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001699737-25-000029","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641489","issuerName":"VTV THERAPEUTICS INC.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2025-12-08","reportingPerson":"Samsara Opportunity Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":152893,"percentOfClass":3.8,"filedAt":"2025-12-09","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001699737-25-000029","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001641489","issuerName":"VTV THERAPEUTICS INC.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2025-12-08","reportingPerson":"Samsara Opportunity Fund, L.P.","reportingCik":"0002086193","personType":"PN","sharesOwned":152893,"percentOfClass":3.8,"filedAt":"2025-12-09","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0002005369-25-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"Raymond Debbane","reportingCik":null,"personType":"IN","sharesOwned":393098,"percentOfClass":9.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0002005369-25-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"Siren, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":345926,"percentOfClass":8.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0002005369-25-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"Invus Public Equities Advisors, LLC","reportingCik":null,"personType":"OO","sharesOwned":345926,"percentOfClass":8.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0002005369-25-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"Invus Public Equities, L.P.","reportingCik":null,"personType":"PN","sharesOwned":345926,"percentOfClass":8.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0002005369-25-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"Invus Global Management, LLC","reportingCik":null,"personType":"OO","sharesOwned":345926,"percentOfClass":8.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0002005369-25-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"Avicenna Life Sci Master GP LLC","reportingCik":null,"personType":"OO","sharesOwned":47172,"percentOfClass":1.2,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0002005369-25-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"Avicenna Life Sci Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":47172,"percentOfClass":1.2,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0002005369-25-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001641489","issuerName":"vTv Therapeutics Inc.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"Ulys, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":47172,"percentOfClass":1.2,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001699737-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001641489","issuerName":"VTV THERAPEUTICS INC.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2025-09-22","reportingPerson":"Srinivas Akkaraju","reportingCik":"0001253170","personType":"IN","sharesOwned":343223,"percentOfClass":9.9,"filedAt":"2025-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001699737-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001641489","issuerName":"VTV THERAPEUTICS INC.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2025-09-22","reportingPerson":"Samsara BioCapital, L.P.","reportingCik":"0001699737","personType":"PN","sharesOwned":221084,"percentOfClass":6.5,"filedAt":"2025-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001699737-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001641489","issuerName":"VTV THERAPEUTICS INC.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2025-09-22","reportingPerson":"Samsara BioCapital GP, LLC","reportingCik":"0001888829","personType":"OO","sharesOwned":221084,"percentOfClass":6.5,"filedAt":"2025-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001699737-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001641489","issuerName":"VTV THERAPEUTICS INC.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2025-09-22","reportingPerson":"Samsara Opportunity Fund, L.P.","reportingCik":"0002086193","personType":"PN","sharesOwned":118073,"percentOfClass":3.5,"filedAt":"2025-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"},{"accessionNo":"0001699737-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001641489","issuerName":"VTV THERAPEUTICS INC.","ticker":"VTVT","cusip":null,"securityClass":"Class A Common Stock, par value $0.01 per share","eventDate":"2025-09-22","reportingPerson":"Samsara Opportunity Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":118073,"percentOfClass":3.5,"filedAt":"2025-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt"}],"updatedAt":"2026-11-03T18:39:45.521Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/vtvt","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}